1. |
广何. 专家呼吁: 应积极应对多重耐药菌的挑战. (2019-05-20)[2021-03-05]. https://baijiahao.baidu.com/s?id=1634057386504265905&wfr=spider&for=pc.
|
2. |
胡付品, 郭燕, 朱德妹, 等. 2017 年 CHINET 中国细菌耐药性监测. 中国感染与化疗杂志, 2018, 18(3): 241-251.
|
3. |
Huang W, Qiao F, Zhang Y, et al. In-hospital medical costs of infections caused by Carbapenem-resistant Klebsiella pneumoniae. Clin Infect Dis, 2018, 67(suppl 2): S225-S230.
|
4. |
张建娜, 陈晓莉, 叶磊. 急诊 ICU 多重耐药菌医院感染控制的综合干预效果评价. 护理管理杂志, 2017, 17(12): 926-928.
|
5. |
Qiao F, Huang W, Gao S, et al. Risk factor for intestinal carriage of carbapenem-resistant Acinetobacter baumannii and the impact on subsequent infection among patients in an intensive care unit: an observational study. BMJ Open, 2020, 10(9): e035893.
|
6. |
World Health Organization. Guidelines for the prevention and control of carbapenem-resistant Enterobacteriaceae, Acinetobacter baumannii and Pseudomonas aeruginosa in health care facilities. (2017-11-01)[2021-03-05]. https://www.who.int/infection-prevention/publications/guidelines-cre/en/.
|
7. |
Centers for Disease Control. Facility guidance for control of carbapenem-resistant Enterobacteriaceae (CRE). (2015-11-01)[2021-03-05]. https://www.cdc.gov/hai/pdfs/cre/CRE-guidance-508.pdf.
|
8. |
Nutman A, Lerner A, Schwartz D, et al. Evaluation of carriage and environmental contamination by carbapenem-resistant Acinetobacter baumannii. Clin Microbiol Infect, 2016, 22(11): 949.e5-949.e7.
|
9. |
Cheng VC, Chen JH, So SY, et al. Use of fluoroquinolones is the single most important risk factor for the high bacterial load in patients with nasal and gastrointestinal colonization by multidrug-resistant Acinetobacter baumannii. Eur J Clin Microbiol Infect Dis, 2015, 34(12): 2359-2366.
|
10. |
陈美恋, 王守军, 匡季秋, 等. 重症监护病区 CRE 主动筛查及其效果评价. 中华医院感染学杂志, 2017, 27(18): 4123-4126.
|
11. |
Chen X, Liu Q, Liu WE, et al. Risk factors for subsequential carbapenem-resistant Klebsiella pneumoniae clinical infection among rectal carriers with carbapenem-resistant Klebsiella pneumoniae. Infect Drug Resist, 2020, 13: 1299-1305.
|
12. |
Mammina C, Bonura C, Vivoli AR, et al. Co-colonization with carbapenem-resistant Klebsiella pneumoniae and Acinetobacter baumannii in intensive care unit patients. Scand J Infect Dis, 2013, 45(8): 629-634.
|
13. |
Karaaslan A, Soysal A, Altinkanat Gelmez G, et al. Molecular characterization and risk factors for carbapenem-resistant Gram-negative bacilli colonization in children: emergence of NDM-producing Acinetobacter baumannii in a newborn intensive care unit in Turkey. J Hosp Infect, 2016, 92(1): 67-72.
|
14. |
Latibeaudiere R, Rosa R, Laowansiri P, et al. Surveillance cultures growing carbapenem-resistant Acinetobacter baumannii predict the development of clinical infections: a retrospective cohort study. Clin Infect Dis, 2015, 60(3): 415-422.
|
15. |
Dickstein Y, Edelman R, Dror T, et al. Carbapenem-resistant Enterobacteriaceae colonization and infection in critically ill patients: a retrospective matched cohort comparison with non-carriers. J Hosp Infect, 2016, 94(1): 54-59.
|
16. |
Tischendorf J, de Avila RA, Safdar N. Risk of infection following colonization with carbapenem-resistant Enterobactericeae:a systematic review. Am J Infect Control, 2016, 44(5): 539-543.
|
17. |
van Loon K, Voor In’t Holt AF, Vos MC. A systematic review and meta-analyses of the clinical epidemiology of carbapenem-resistant Enterobacteriaceae. Antimicrob Agents Chemother, 2017, 62(1): e01730-17.
|
18. |
Sultan AM, Seliem WA. Identifying risk factors for healthcare-associated infections caused by carbapenem-resistant Acinetobacter baumannii in a neonatal intensive care unit. Sultan Qaboos Univ Med J, 2018, 18(1): e75-e80.
|
19. |
杨艳兵, 李从荣. 基于显色培养法多重耐药鲍曼不动杆菌快速筛查方法的建立. 中华实验和临床感染病杂志(电子版), 2015(1): 32-34.
|
20. |
卫丽, 乔甫, 林吉, 等. 经修饰 CHROMagar 不动杆菌显色培养联合 MALDI-TOF-MS 快速筛查肠道耐碳青霉烯鲍氏不动杆菌的研究. 中华医院感染学杂志, 2018, 28(19): 2893-2897.
|